Paper40200415
Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid.
Dong Y and 8 others. Ultrasonography, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid. Papers, record 40200415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40200415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35229334 | Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. | Aliment Pharmacol Ther | 2022 | https://conductscience.org/library/papers/35229334 | PubMed |
| 2 | 33069987 | Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics. | Eur J Radiol | 2020 | https://conductscience.org/library/papers/33069987 | PubMed |
| 3 | 28718042 | Contrast enhanced ultrasound for focal liver lesions: how accurate is it? | Abdom Radiol (NY) | 2018 | https://conductscience.org/library/papers/28718042 | PubMed |
| 4 | 33672827 | Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33672827 | PubMed |
| 5 | 34904038 | Abnormal liver enzymes: A review for clinicians. | World J Hepatol | 2021 | https://conductscience.org/library/papers/34904038 | PubMed |
| 6 | 29122695 | Should we undertake surveillance for HCC in patients with NAFLD? | J Hepatol | 2018 | https://conductscience.org/library/papers/29122695 | PubMed |
| 7 | 31521875 | MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH). | Eur J Radiol | 2019 | https://conductscience.org/library/papers/31521875 | PubMed |
| 8 | 31085617 | Diagnosis and management of non-alcoholic fatty liver disease. | Postgrad Med J | 2019 | https://conductscience.org/library/papers/31085617 | PubMed |
| 9 | 35710501 | Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study. | Ultrasound Med Biol | 2022 | https://conductscience.org/library/papers/35710501 | PubMed |
| 10 | 36291962 | Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36291962 | PubMed |
| 11 | 30074820 | Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. | Br J Radiol | 2018 | https://conductscience.org/library/papers/30074820 | PubMed |
| 12 | 36140576 | Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/36140576 | PubMed |
| 13 | 29209739 | Hepatocarcinogenesis and LI-RADS. | Abdom Radiol (NY) | 2018 | https://conductscience.org/library/papers/29209739 | PubMed |
| 14 | 36789250 | Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Using Contrast-Enhanced Ultrasound-Based Deep-Learning Radiomics Model. | J Hepatocell Carcinoma | 2023 | https://conductscience.org/library/papers/36789250 | PubMed |
| 15 | 26989655 | Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma. | Liver Cancer | 2016 | https://conductscience.org/library/papers/26989655 | PubMed |
| 16 | 32447876 | The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid. | Ultrasonography | 2020 | https://conductscience.org/library/papers/32447876 | PubMed |
| 17 | 26558795 | Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. | Hepatol Int | 2016 | https://conductscience.org/library/papers/26558795 | PubMed |
| 18 | 33748726 | NAFLD and MAFLD as emerging causes of HCC: A populational study. | JHEP Rep | 2021 | https://conductscience.org/library/papers/33748726 | PubMed |
| 19 | 32115307 | Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System. | Ultrasound Med Biol | 2020 | https://conductscience.org/library/papers/32115307 | PubMed |
| 20 | 17620943 | Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions? | Invest Radiol | 2007 | https://conductscience.org/library/papers/17620943 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41802329 | Kupffer-phase Sonazoid ultrasound LI-RADS for liver cancer: diagnostic performance and algorithm modification. | Ultrasonography | 2026 | https://conductscience.org/library/papers/41802329 | PubMed |
| 41566984 | Ultrasonography in 2026: accelerating progress and defining the future of ultrasound. | Ultrasonography | 2026 | https://conductscience.org/library/papers/41566984 | PubMed |
| 41463285 | HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41463285 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40200415
GET https://conductscience.org/api/papers/v1/40200415/references?page=2